The government has pushed for standards for the payment of those involved in the World Health Organization (WHO) solidarity trial and independent clinical trials of coronavirus disease 2019 (Covid-19).
This evolved after the Interagency Working Group on the Management of Emerging Infectious Diseases (IATF) on Thursday approved the recommendations of the running sub-technical organization on the progression of the Covid-19 vaccine.
“The Philippine Health Research Ethics Council (PHREB) reviews the moral rules for Covid-19 clinical trials and standardizes the remuneration of trial participants for both the WHO Solidarity Trial and Independent Clinical Trials,” says IATF Resolution 64.
On the basis of the new resolution, all clinical trial programs should first be submitted to the Committee of Vaccine Experts, reviewed through designated ethics committees, and submitted to the Food and Drug Administration for review and approval for clinical trials.
Zoning rules on clinical trials of vaccines will be published through the Technical Working Group on Vaccine Development to Avoid Festivals on Sites.
Local government also prioritizes WHO solidarity testing on independent trials.
The Philippines is expected to conduct phase 3 clinical trials for 4 vaccines that have effectively completed the WHO prequalification process.
The country is also lately in talks with pharmaceutical corporations in other countries about Covid-19 vaccines for imaginable collaborations for clinical trials.
President Rodrigo Duterte accepted Russia’s offer to supply the Philippines with its Covid-19 vaccines and even promised to be the first to check its fate to show its gratitude to Russia and see if they were or not.
However, Malacaang stated that the president may not be vaccinated until May 1, 2021, a date we decided through the Ministry of Science and Technology and the Ministry of Health.
The third phase of the Sputnik V clinical trials through the Gamaleya Institute of Epidemiology and Microbiology Research will take place in the Philippines and Russia from October 2020 to March 2021.
The vaccine is expected to be registered with the Food and Drug Administration until April 2021.
You have effectively joined our subscriber list.